Literature DB >> 26388227

Bone diseases: Targeting myostatin for direct joint defence.

Natasha Bray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26388227     DOI： 10.1038/nrd4745

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice.

Authors:  Berno Dankbar; Michelle Fennen; Daniela Brunert; Silvia Hayer; Svetlana Frank; Corinna Wehmeyer; Denise Beckmann; Peter Paruzel; Jessica Bertrand; Kurt Redlich; Christina Koers-Wunrau; Athanasios Stratis; Adelheid Korb-Pap; Thomas Pap
Journal:  Nat Med       Date:  2015-08-03       Impact factor: 53.440
  1 in total
  1 in total

1.  Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model.

Authors:  Tero Puolakkainen; Petri Rummukainen; Jemina Lehto; Olli Ritvos; Ari Hiltunen; Anna-Marja Säämänen; Riku Kiviranta
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.